RenovoRx, Inc.

RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
Investing News Network · 22 Oct 2026
RenovoRx, Inc. SEC Filing (Oct 16, 2026)
Stock Titan · 16 Oct 2026
Here's Why We're Watching RenovoRx's (NASDAQ:RNXT) Cash Burn Situation
Simply Wall Street · 07 Oct 2026
RenovoRx reports case series on pancreatic cancer treatment By Investing.com
Investing.com Canada · 01 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.